Page last updated: 2024-09-05

odiparcil and dalteparin

odiparcil has been researched along with dalteparin in 1 studies

*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]

*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]

Compound Research Comparison

Studies
(odiparcil)
Trials
(odiparcil)
Recent Studies (post-2010)
(odiparcil)
Studies
(dalteparin)
Trials
(dalteparin)
Recent Studies (post-2010) (dalteparin)
132105,6651,4232,267

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eddington, ND; Khurana, M; Myers, AL; Upreti, VV1

Trials

1 trial(s) available for odiparcil and dalteparin

ArticleYear
Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:10

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aspirin; Chromatography, High Pressure Liquid; Drug Interactions; Enoxaparin; Female; Fibrinolytic Agents; Glycosaminoglycans; Glycosides; Humans; Liver Function Tests; Male; Middle Aged; Young Adult

2008